What levofloxacin dose should be given for prophylaxis of a shoe‑puncture wound on the sole of an adult's foot with normal renal function?

Levofloxacin is NOT recommended for prophylaxis of puncture wounds through shoes

Antibiotic prophylaxis for puncture wounds of the foot through shoes should use an agent with anti-pseudomonal coverage, but levofloxacin is not the standard choice for this indication. While one study showed that oral antibiotics given within 24 hours prevented infection in puncture wounds 1, and levofloxacin has activity against Pseudomonas aeruginosa (a key pathogen in shoe-puncture wounds), there are no guidelines or FDA-approved indications supporting levofloxacin specifically for this prophylactic use.

Key Clinical Considerations

The primary concern with puncture wounds through shoes is Pseudomonas aeruginosa infection, which can colonize the foam insoles of athletic shoes. The study by 1 demonstrated that 3 of 7 children who developed infections had P. aeruginosa, and prophylactic antibiotics within 24 hours prevented all infections (P < 0.05).

Why Levofloxacin Dosing is Problematic Here

The available evidence addresses levofloxacin dosing for treatment of established infections, not prophylaxis:

• FDA-approved treatment doses: 500-750 mg daily for various infections 2
• Urologic prophylaxis: 500 mg single dose for specific procedures 3
• Tuberculosis treatment: 500-1,000 mg daily 4, 5, 4

None of these contexts match puncture wound prophylaxis, which typically requires:

• Short-term coverage (3-5 days)
• Anti-pseudomonal activity
• Consideration of local resistance patterns

Standard Approach to Puncture Wounds

For puncture wounds through shoes in adults with normal renal function:

1. Wound management is primary: Thorough irrigation, debridement of devitalized tissue, avoid primary closure 6

2. Antibiotic prophylaxis considerations:

   • Indicated if given within 24 hours of injury 1
   • Must cover P. aeruginosa and skin flora
   • Traditional choices include ciprofloxacin (which has better anti-pseudomonal activity than levofloxacin)

3. If levofloxacin were to be used (extrapolating from treatment data):

   • 500 mg orally daily would be the minimum dose 2
   • 750 mg daily provides higher tissue concentrations 7
   • Duration: 3-5 days based on general wound prophylaxis principles 6
   • Must ensure adequate hydration 2
   • Avoid concurrent antacids, iron, or multivitamins (separate by 2 hours) 2

Important Caveats

Fluoroquinolone resistance in P. aeruginosa is a growing concern—local antibiograms should guide empiric choices. The tissue penetration data 7 shows levofloxacin achieves adequate concentrations in skin and soft tissue (mean 19.9 mcg/g in skin after 500 mg IV), but this doesn't establish efficacy for prophylaxis.

Ciprofloxacin remains the preferred fluoroquinolone for pseudomonal coverage in most guidelines when a fluoroquinolone is chosen, as it has superior anti-pseudomonal activity compared to levofloxacin.

Renal Function Adjustment

Since you specified normal renal function, no adjustment needed. However, if creatinine clearance <50 mL/min, levofloxacin requires dose reduction to 750-1,000 mg three times weekly 4.